跳至主要内容
临床试验/CTRI/2023/04/051582
CTRI/2023/04/051582尚未招募3 期

Effect of co-enzyme Q10 add-on therapy in patients with major depressive disorder on standard anti-depressant therapy: A randomized, double blind, placebo-controlled trial

AIIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
AIIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All adult patients of either sex aged 18-65 years with clinical diagnosis of Major Depressive Disorder as per DSM-5 criteria.
  • 2. Patients on stable dose (no change in dose) of anti-depressants for 4 weeks.
  • 3. Patients willing to participate and give consent.

排除标准

  • 1. Patients with comorbid psychiatric or neurological disorders such as anxiety disorder, schizophrenia, current state of psychosis, epilepsy and substance use disorder
  • 2. Patient currently having suicidal ideas or history of suicidal plan/attempt.
  • ï?§ Pregnancy or lactation or expecting to get pregnant during the treatment.
  • ï?§ Patient on concomitant warfarin therapy, anti-hypertensive drugs or statins.
  • ï?§ Patients with chronic liver disease.
  • ï?§ Poor adherence to medications.
  • ï?§ Patient not willing to give consent.

研究者

发起方
AIIMS

相似试验